Shenzhen Weiguang Biological Products Co Ltd - Asset Resilience Ratio

Latest as of June 2024: 5.52%

Shenzhen Weiguang Biological Products Co Ltd (002880) has an Asset Resilience Ratio of 5.52% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 002880 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥169.93 Million

≈ $24.87 Million USD Cash + Short-term Investments

Total Assets

CN¥3.08 Billion

≈ $450.47 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Shenzhen Weiguang Biological Products Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 002880 asset base.

Liquid Assets Composition Over Time

This chart breaks down Shenzhen Weiguang Biological Products Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 002880 total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥169.93 Million	5.52%
Total Liquid Assets	CN¥169.93 Million	5.52%

Asset Resilience Insights

Limited Liquidity: Shenzhen Weiguang Biological Products Co Ltd maintains only 5.52% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shenzhen Weiguang Biological Products Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shenzhen Weiguang Biological Products Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for Shenzhen Weiguang Biological Products Co Ltd (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Shenzhen Weiguang Biological Products Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	4.65%	CN¥153.32 Million ≈ $22.43 Million	CN¥3.30 Billion ≈ $482.52 Million	+27.52pp
2023-12-31	-22.87%	CN¥-658.04 Million ≈ $-96.29 Million	CN¥2.88 Billion ≈ $420.96 Million	-15.75pp
2022-12-31	-7.12%	CN¥-183.51 Million ≈ $-26.85 Million	CN¥2.58 Billion ≈ $376.91 Million	-5.95pp
2021-12-31	-1.17%	CN¥-23.53 Million ≈ $-3.44 Million	CN¥2.00 Billion ≈ $293.18 Million	-0.94pp
2020-12-31	-0.23%	CN¥-4.25 Million ≈ $-621.91K	CN¥1.84 Billion ≈ $268.69 Million	--

pp = percentage points

About Shenzhen Weiguang Biological Products Co Ltd

SHE:002880 China Biotechnology

Market Cap

$690.31 Million

CN¥4.72 Billion CNY

Market Cap Rank

#10726 Global

#2935 in China

Share Price

CN¥20.80

Change (1 day)

+0.43%

52-Week Range

CN¥18.80 - CN¥31.04

All Time High

CN¥963796.17